Prevalon
Device Medical
PDI 00618029980014
General payments
$142,507
Research payments
$14,430
Through program year 2025, $142,507 in general payments and $14,430 in research payments were reported against Prevalon (Medical).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $59,640 | 197 |
| 2024 | General | $39,127 | 146 |
| 2023 | General | $43,020 | 147 |
| 2022 | General | $491 | 16 |
| 2021 | General | $230 | 8 |
| 2021 | Research | $14,430 | 4 |
Breakdown
The top 5 of 70 recipients; each share is of general payments naming this product in 2025.
The top 5 of 25 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 22 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
514 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.